“This is a transformative moment for women in America.  Beginning today, we will change the reality of women’s health. Previous generations fought for women's rights.  Our generation will fight to discover the cures that will ensure a woman can live her lifein health and to the fullest.” – First Lady Melania Trump

Mission S. Authentic. Consistent. Timeless. A glimpse into the future - shaped by our heritage. Mid-engine architecture. A focus on the driver and the driving experience. Call it a love letter.

🚨 BREAKING: The Trump admin is BANNING tech firm Cloudera from the PERM foreign worker program for 2 YEARS after it discriminated against American workers, DOJ and Harmeet Dhillon confirm as part of a settlement BOOM!! 🔥 It's also paying $1.4 MILLION in BACKPAY to the American workers it passed over, plus $600,000 in civil penalties This comes after a recent announcement where Trump admin suspended PERM for a FLURRY of other tech firms. The DOJ and the Labor Department say the Santa Clara data company shut qualified U.S. workers out of multiple jobs it was filling through the PERM green card sponsorship process A company is only supposed to sponsor a foreigner if no qualified American is available. Cloudera didn't give Americans a chance DOJ sued the company back in April, and Labor had already suspended its PERM processing before this deal AAG HARMEET DHILLON: "The Justice Department will hold accountable employers who discriminate against U.S. workers." AMERICANS FIRST! 🇺🇸🇺🇸

Journal of Urology publication of our updated 100 patients with long-term data in BCG unresponsive non muscle invasive bladder cancer. Responses extending beyond 53 months! 84% cystectomy free survival at 36 months. NK cells matters. Chemotherapy reduces lymphocytes. Next, BCG naive in non muscle invasive bladder cancer. businesswire.com/news/home/2…

Anktiva is a modified interleukin-15. IL-15 is a signal your immune system uses to wake up natural killer cells and T cells. That is why it works as a cancer drug. BCG is an old bacteria treatment for the bladder. The immune system reacts to it and the tumor gets caught in that reaction. Add IL-15 and you are sending a louder signal to the same cells. We have been injecting interleukins straight into tumors for years. No single cytokine beats cancer alone. You have to change a lot in the immune system at once. A bladder-only approval means most cancer patients still can’t get this drug. Inject it into the tumor and the list of cancers it helps gets a lot longer. Good step. Now expand it.

Thanks to FDA for approving the platform that stimulates NK and Killer T cells. Memory T cells and durable responses is the next evolution of immunotherapy.

We are pleased to announce that the U.S. Food and Drug Administration (@FDA) has expanded the indication for ANKTIVA® (nogapendekin alfa inbakicept‑pmln) + BCG to include patients with BCG‑unresponsive non‑muscle‑invasive bladder cancer (NMIBC) with papillary‑only tumors. This milestone makes ANKTIVA + BCG the first FDA‑approved therapy for both CIS and papillary‑only disease in the BCG‑unresponsive NMIBC setting. Because papillary tumors represent approximately 85 % of NMIBC diagnoses, this approval significantly broadens access to a bladder‑sparing option for patients who face high risk of recurrence and progression. Read more: immunitybio.com/fda-expands-…

If you want to open a sandwich shop, food inspectors must first determine that it’s safe. If you’re a Big Tech Oligarch who builds an AI product that could threaten the human race? That product won’t be subject to 1 safety regulation. That’s insane. We must regulate AI — NOW!

Big news for bladder cancer patients! FDA just expanded approval of Anktiva with BCG for adults with BCG-unresponsive, high-grade papillary-only NMIBC — the first treatment approved for this group. This is a first, and that matters. Evidence from a closely related form of bladder cancer supported the approval. fda.gov/drugs/resources-info…

NEW: The Congressional watchdog released a report on Trump’s dangerous cuts to HUD, the federal agency where Americans go for help with their housing. The verdict: illegal funding delays, huge staff cuts leaving phones unanswered, and civil rights falling by the wayside.

Big news for bladder cancer patients! FDA just expanded approval of Anktiva with BCG for adults with BCG-unresponsive, high-grade papillary-only NMIBC — the first treatment approved for this group. This is a first, and that matters. Evidence from a closely related form of bladder cancer supported the approval. fda.gov/drugs/resources-info…

Today feels like the hottest day of the whole trip. It’s October 12 and we have 93 Fahrenheit (34°C)… Crazy thing is that this Saturday it’s supposed to drop to just 67 (19°C). We still used the day to see more of the Texas State Fair and also went to the JFK assassination site here in Dallas.

Medical breakthroughs shouldn't take decades to reach the patients who need them. Under @POTUS and @SecKennedy, HHS is modernizing clinical trials to cut delays, reduce costs, and accelerate medical innovation. Through @ARPA_H's new SURPASS program and three complementary initiatives, we're harnessing AI, advanced technology, and real-time data to make clinical trials faster, smarter, and less burdensome for patients. America should lead the world in medical innovation, and we're working to make sure promising treatments reach patients sooner.

I’m ok. Make no mistake: this is an attempt to target political enemies and weaponize federal law enforcement. For ten years, Trump has targeted me with baseless lies and smear campaigns. This is just the latest escalation in his campaign of political intimidation. I will not be silenced.

Illhan Omar: "I would have gotten away with it too, if it wasn't for that meddling kid!"